Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018356 · ClinicalTrials.gov registry record · Phase 4
Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
A Phase 4 study of Muscle Weakness and Muscular Atrophy, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT00018356: Completed Phase 4 study of Muscle Weakness and Muscular Atrophy, sponsored by US Department of Veterans Affairs.
NCT00018356 is a Phase 4 study of Muscle Weakness and Muscular Atrophy that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 88 participants, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018356, a Phase 4 study of Muscle Weakness and Muscular Atrophy, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
Conditions Studied
Interventions
- DRUG testosterone
- PROCEDURE exercise
Study Locations (1)
Arkansas
- Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock - No. Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 1999-01 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
What the finished NCT00018356 record still lists
NCT00018356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (24% higher).
The record links to 2 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which testosterone is the first listed.
NCT00018356 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00018356 about?
NCT00018356 is a clinical study titled "Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly". This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
What is the current status of trial NCT00018356?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 1999-01. Estimated completion is 2006-08.
What conditions does trial NCT00018356 study?
This clinical trial studies the following conditions: Muscle Weakness, Muscular Atrophy.
What interventions are being tested in trial NCT00018356?
The interventions under investigation include: testosterone (DRUG), exercise (PROCEDURE).
Who is sponsoring clinical trial NCT00018356?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00018356 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00018356's enrollment target sits among peer trials
88 6th of 25 higher than 20 of 25 other Muscle Weakness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Muscle Weakness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Depo-Medrol on Psoas After LLIF
RECRUITING · Phase 4
-
Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex
COMPLETED · Phase 4
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RECRUITING
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
Muscle Recovery After Critical Illness
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia